BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/4/2014 3:52:00 PM | Browse: 1360 | Download: 671
Publication Name World Journal of Gastroenterology
Manuscript ID 8686
Country/Territory United States
Received
2014-01-02 10:18
Peer-Review Started
To Make the First Decision
Return for Revision
Revised
2014-01-01 00:00
Second Decision
2014-01-05 14:41
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-01-05 15:26
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
2014-01-05 15:30
Typeset the Manuscript
2014-01-05 19:56
Publish the Manuscript Online
2014-01-19 14:17
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © 2014 Baishideng Publishing Group Co., Limited. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Cell Biology
Manuscript Type Topic Highlights
Article Title Epigenetics in hepatocellular carcinoma: An update and future therapy perspectives
Manuscript Source Invited Manuscript
All Author List Li Ma, Mei-Sze Chua, Ourania Andrisani and Samuel So
Funding Agency and Grant Number
Corresponding Author Dr. Mei-Sze Chua, PhD, Asian Liver Center and Department of Surgery, Stanford University School of Medicine, Stanford University, 1201 Welch Rd, MSLS Building, Stanford, CA 94305, United States. mchua@stanford.edu
Key Words Hepatocellular carcinoma; Epigenetics; DNA methylation; Histone modification; miRNA; lncRNA
Core Tip Hepatocellular carcinoma (HCC) is a global health concern; molecularly targeted therapeutics remains limited to sorafenib. New targets and drugs are urgently needed to broaden the limited treatment options for HCC. Many lines of evidence suggest that epigenetics is associated with the initiation and development of HCC. Here, we review the current state of knowledge on epigenetic deregulation in HCC, and potential therapies that can be exploited for interventions.
Publish Date 2014-01-19 14:17
Citation Ma L, Chua MS, Andrisani O, So S. Epigenetics in hepatocellular carcinoma: An update and future therapy perspectives. World J Gastroenterol 2014; 20(2): 333-345
URL http://www.wjgnet.com/1007-9327/full/v20/i2/333.htm
DOI http://dx.doi.org/10.3748/wjg.v20.i2.333
Full Article (PDF) WJG-20-333.pdf
Full Article (Word) WJG-20-333.doc
Manuscript File 8686-Review.docx
Answering Reviewers 8686-Answering reviewers.PDF
Copyright License Agreement 8686-Copyright assignment.PDF
Peer-review Report 8686-Peer review(s).pdf
Scientific Editor Work List 8686-Scientific editor work list.doc